These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24350871)

  • 1. Estimating the annual number of strokes and the issue of imperfect data: an example from Australia.
    Cadilhac DA; Vos T; Thrift AG
    Int J Stroke; 2014 Jan; 9(1):19-22. PubMed ID: 24350871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS).
    Thrift AG; Dewey HM; Macdonell RA; McNeil JJ; Donnan GA
    Stroke; 2000 Sep; 31(9):2087-92. PubMed ID: 10978034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS).
    Cadilhac DA; Carter R; Thrift AG; Dewey HM
    Stroke; 2009 Mar; 40(3):915-21. PubMed ID: 19182091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of stroke recurrence according to subtype of first stroke event: the North East Melbourne Stroke Incidence Study (NEMESIS).
    Azarpazhooh MR; Nicol MB; Donnan GA; Dewey HM; Sturm JW; Macdonell RA; Pearce DC; Thrift AG
    Int J Stroke; 2008 Aug; 3(3):158-64. PubMed ID: 18705891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS).
    Cadilhac DA; Dewey HM; Vos T; Carter R; Thrift AG
    Health Qual Life Outcomes; 2010 May; 8():49. PubMed ID: 20470370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women.
    Thrift AG; Dewey HM; Sturm JW; Srikanth VK; Gilligan AK; Gall SL; Macdonell RA; McNeil JJ; Donnan GA
    Neuroepidemiology; 2009; 32(1):11-8. PubMed ID: 18997472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS).
    Dewey HM; Thrift AG; Mihalopoulos C; Carter R; Macdonell RA; McNeil JJ; Donnan GA
    Stroke; 2001 Oct; 32(10):2409-16. PubMed ID: 11588334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability burden due to stroke in Western Australia: new insights from linked data sources.
    Katzenellenbogen JM; Begg S; Somerford P; Anderson CS; Semmens JB; Codde JP; Vos T
    Int J Stroke; 2010 Aug; 5(4):269-77. PubMed ID: 20636709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data.
    Roumie CL; Mitchel E; Gideon PS; Varas-Lorenzo C; Castellsague J; Griffin MR
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):20-6. PubMed ID: 17979142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term costs of stroke using 10-year longitudinal data from the North East Melbourne Stroke Incidence Study.
    Gloede TD; Halbach SM; Thrift AG; Dewey HM; Pfaff H; Cadilhac DA
    Stroke; 2014 Nov; 45(11):3389-94. PubMed ID: 25342028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a model to estimate stroke incidence in a population.
    Schau B; Boysen G; Truelsen T; Boden-Albala B; Cheng J; Babamoto E; Zaher C; Sacco RL
    J Stroke Cerebrovasc Dis; 2003 Jan; 12(1):22-8. PubMed ID: 17903900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications.
    Cadilhac DA; Carter RC; Thrift AG; Dewey HM
    Health Policy; 2007 Oct; 83(2-3):287-94. PubMed ID: 17368861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke and transient ischemic attack incidence rate in Spain: the IBERICTUS study.
    Díaz-Guzmán J; Egido JA; Gabriel-Sánchez R; Barberá-Comes G; Fuentes-Gimeno B; Fernández-Pérez C;
    Cerebrovasc Dis; 2012; 34(4):272-81. PubMed ID: 23095851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and aetiology of stroke in the Caerphilly and Speedwell Collaborative Studies I: methods and incidence of events.
    Greenwood R; McCarron P; Elwood P; Shlomo YB; Bayer A; Baker I; Frankel S; Ebrahim S; Murray L; Smith GD
    Public Health; 2001 Jan; 115(1):4-11. PubMed ID: 11402346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke surveillance: population-based estimates and projections for New Zealand.
    Tobias M; Cheung J; Carter K; Anderson C; Feigin VL
    Aust N Z J Public Health; 2007 Dec; 31(6):520-5. PubMed ID: 18081570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the in-hospital stroke rate following carotid endarterectomy in California and Maryland.
    Matsen SL; Chang DC; Perler BA; Roseborough GS; Williams GM
    J Vasc Surg; 2006 Sep; 44(3):488-95. PubMed ID: 16950421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registry.
    Abboud H; Labreuche J; Arauz A; Bryer A; Lavados PG; Massaro A; Munoz Collazos M; Steg PG; Yamout BI; Vicaut E; Amarenco P;
    Int J Stroke; 2013 Oct; 8 Suppl A100():4-13. PubMed ID: 22974118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada.
    Caro JJ; Migliaccio-Walle K; Ishak KJ; Proskorovsky I; O'Brien JA
    BMC Health Serv Res; 2006 Aug; 6():99. PubMed ID: 16907982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity burden of end-stage kidney disease in Australia: hospital separation rates among people receiving kidney replacement therapy.
    McDonald SP; Tong B
    Nephrology (Carlton); 2011 Nov; 16(8):758-66. PubMed ID: 21707839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.